These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 37142704)
1. Engineered phage with antibacterial CRISPR-Cas selectively reduce E. coli burden in mice. Gencay YE; Jasinskytė D; Robert C; Semsey S; Martínez V; Petersen AØ; Brunner K; de Santiago Torio A; Salazar A; Turcu IC; Eriksen MK; Koval L; Takos A; Pascal R; Schou TS; Bayer L; Bryde T; Johansen KC; Bak EG; Smrekar F; Doyle TB; Satlin MJ; Gram A; Carvalho J; Jessen L; Hallström B; Hink J; Damholt B; Troy A; Grove M; Clube J; Grøndahl C; Haaber JK; van der Helm E; Zdravkovic M; Sommer MOA Nat Biotechnol; 2024 Feb; 42(2):265-274. PubMed ID: 37142704 [TBL] [Abstract][Full Text] [Related]
2. Covalent Modifications of the Bacteriophage Genome Confer a Degree of Resistance to Bacterial CRISPR Systems. Liu Y; Dai L; Dong J; Chen C; Zhu J; Rao VB; Tao P J Virol; 2020 Nov; 94(23):. PubMed ID: 32938767 [TBL] [Abstract][Full Text] [Related]
3. Phenotypic and genomic analyses of bacteriophages targeting environmental and clinical CS3-expressing enterotoxigenic Escherichia coli (ETEC) strains. Chakraborty S; von Mentzer A; Begum YA; Manzur M; Hasan M; Ghosh AN; Hossain MA; Camilli A; Qadri F PLoS One; 2018; 13(12):e0209357. PubMed ID: 30571788 [TBL] [Abstract][Full Text] [Related]
4. An Engineered λ Phage Enables Enhanced and Strain-Specific Killing of Enterohemorrhagic Escherichia coli. Jin M; Chen J; Zhao X; Hu G; Wang H; Liu Z; Chen WH Microbiol Spectr; 2022 Aug; 10(4):e0127122. PubMed ID: 35876591 [TBL] [Abstract][Full Text] [Related]
5. Phage-delivered sensitisation with subsequent antibiotic treatment reveals sustained effect against antimicrobial resistant bacteria. Liu H; Li H; Liang Y; Du X; Yang C; Yang L; Xie J; Zhao R; Tong Y; Qiu S; Song H Theranostics; 2020; 10(14):6310-6321. PubMed ID: 32483454 [TBL] [Abstract][Full Text] [Related]
6. Engineered Bacteriophages Containing Anti-CRISPR Suppress Infection of Antibiotic-Resistant P. aeruginosa. Qin S; Liu Y; Chen Y; Hu J; Xiao W; Tang X; Li G; Lin P; Pu Q; Wu Q; Zhou C; Wang B; Gao P; Wang Z; Yan A; Nadeem K; Xia Z; Wu M Microbiol Spectr; 2022 Oct; 10(5):e0160222. PubMed ID: 35972246 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic effectiveness of bacteriophages in the rescue of mice with extended spectrum beta-lactamase-producing Escherichia coli bacteremia. Wang J; Hu B; Xu M; Yan Q; Liu S; Zhu X; Sun Z; Tao D; Ding L; Reed E; Gong J; Li QQ; Hu J Int J Mol Med; 2006 Feb; 17(2):347-55. PubMed ID: 16391836 [TBL] [Abstract][Full Text] [Related]
9. Exploitation of the Cooperative Behaviors of Anti-CRISPR Phages. Chevallereau A; Meaden S; Fradet O; Landsberger M; Maestri A; Biswas A; Gandon S; van Houte S; Westra ER Cell Host Microbe; 2020 Feb; 27(2):189-198.e6. PubMed ID: 31901522 [TBL] [Abstract][Full Text] [Related]
10. Experimental Evolution of the TolC-Receptor Phage U136B Functionally Identifies a Tail Fiber Protein Involved in Adsorption through Strong Parallel Adaptation. Burmeister AR; Tzintzun-Tapia E; Roush C; Mangal I; Barahman R; Bjornson RD; Turner PE Appl Environ Microbiol; 2023 Jun; 89(6):e0007923. PubMed ID: 37191555 [TBL] [Abstract][Full Text] [Related]
11. High-throughput mapping of the phage resistance landscape in E. coli. Mutalik VK; Adler BA; Rishi HS; Piya D; Zhong C; Koskella B; Kutter EM; Calendar R; Novichkov PS; Price MN; Deutschbauer AM; Arkin AP PLoS Biol; 2020 Oct; 18(10):e3000877. PubMed ID: 33048924 [TBL] [Abstract][Full Text] [Related]
12. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli. Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884 [TBL] [Abstract][Full Text] [Related]
13. Revealing bacteria-phage interactions in human microbiome through the CRISPR-Cas immune systems. Monshizadeh M; Zomorodi S; Mortensen K; Ye Y Front Cell Infect Microbiol; 2022; 12():933516. PubMed ID: 36250060 [TBL] [Abstract][Full Text] [Related]
16. Phages, anti-CRISPR proteins, and drug-resistant bacteria: what do we know about this triad? Ceballos-Garzon A; Muñoz AB; Plata JD; Sanchez-Quitian ZA; Ramos-Vivas J Pathog Dis; 2022 Oct; 80(1):. PubMed ID: 36255384 [TBL] [Abstract][Full Text] [Related]
17. My host's enemy is my enemy: plasmids carrying CRISPR-Cas as a defence against phages. Siedentop B; Rüegg D; Bonhoeffer S; Chabas H Proc Biol Sci; 2024 Jan; 291(2015):20232449. PubMed ID: 38262608 [TBL] [Abstract][Full Text] [Related]
18. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR mBio; 2017 Oct; 8(5):. PubMed ID: 29089428 [TBL] [Abstract][Full Text] [Related]
19. Phage Engineering for Targeted Multidrug-Resistant Song J; Liu Z; Zhang Q; Liu Y; Chen Y Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768781 [TBL] [Abstract][Full Text] [Related]